View Older Stories View More Recent Stories

May 26, 2015 08:00AM Mast Therapeutics Announces Initiation Of EPIC-E Study
May 11, 2015 08:00AM Mast Therapeutics Reports First Quarter 2015 Financial Results
Apr 21, 2015 08:00AM Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark
Apr 9, 2015 08:00AM Mast To Present New Data Supporting Vepoloxamer (MST-188) In Sickle Cell Disease At 9th Annual Sickle Cell Disease Research And Education Symposium And 38th National Sickle Cell Disease Scientific Mee
Mar 24, 2015 08:00AM Mast Therapeutics Reports Fourth Quarter And Full Year 2014 Financial Results
Mar 23, 2015 08:00AM Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure
Jan 6, 2014 09:37AM Pre-Open Stock Movers 1/6: (SCTY) (RDWR) (SIRI) Higher; (SCSS) (HGG) (TWTR) Lower (more...)
View More Recent Stories View Older Stories